New approaches to preventing restenosis

被引：67

作者：

Bhargava, B ^{[1
]}

Karthikeyan, G

Abizaid, AS

Mehran, R

机构：

[1] All India Inst Med Sci, Dept Cardiol, Cardiothorac Sci Ctr, New Delhi 110029, India

[2] Danta Pazzanese Inst Cardiol, Sao Paulo, Brazil

[3] Cardiovasc Res Fdn, New York, NY USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7409期

关键词：

D O I：

10.1136/bmj.327.7409.274

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

For over a quarter of a century percutaneous coronary interventions have been used to treat patients with coronary artery disease, yet restenosis continues to be a problem. This review discusses the advances being made to overcome restenosis, particularly the development of drug eluting stents

引用

页码：274 / 279

页数：14

共 79 条

[61]

SHARMA SK, 1999, EUR HEART J, V20, pA281

[62]

Simonton CA, 1998, CIRCULATION, V97, P332

[63] ACC/AHA guidelines for percutaneous coronary intervention (Revision of the 1993 PTCA guidelines) - Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) [J].

Smith, SC ;

Dove, JT ;

Jacobs, AK ;

Kennedy, JW ;

Kereiakes, D ;

Kern, MJ ;

Kuntz, RE ;

Popma, JJ ;

Schaff, HV ;

Williams, DO ;

Gibbons, RJ ;

Alpert, JP ;

Eagle, KA ;

Faxon, DP ;

Fuster, V ;

Gardner, TJ ;

Gregoratos, G ;

Russell, RO ;

Smith, SC .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (08) :2215-2238

[64] Sustained suppression of neointimal proliferation by sirolimus-eluting stents - One-year angiographic and intravascular ultrasound follow-up [J].

Sousa, JE ;

Costa, MA ;

Abizaid, AC ;

Rensing, BJ ;

Abizaid, AS ;

Tanajura, LF ;

Kozuma, K ;

Van Langenhove, G ;

Sousa, AGMR ;

Falotico, R ;

Jaeger, J ;

Popma, JJ ;

Serruys, PW .

CIRCULATION, 2001, 104 (17) :2007-2011

[65]

Sousa JE, 2001, CIRCULATION, V103, P192

[66]

Tamai H, 2000, CIRCULATION, V102, P399

[67] TAXUS III trial -: In-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation [J].

Tanabe, K ;

Serruys, PW ;

Grube, E ;

Smits, PC ;

Selbach, G ;

van der Giessen, WJ ;

Staberock, M ;

de Feyter, P ;

Müller, R ;

Regar, E ;

Degertekin, M ;

Ligthart, JMR ;

Disco, C ;

Backx, B ;

Russell, ME .

CIRCULATION, 2003, 107 (04) :559-564

[68] Probucol and multivitamins in the prevention of restenosis after coronary angioplasty [J].

Tardif, JC ;

Cote, G ;

Lesperance, J ;

Bourassa, M ;

Lambert, J ;

Doucet, S ;

Bilodeau, L ;

Nattel, S ;

deGuise, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :365-372

[69] Catheter-based radiotherapy to inhibit restenosis after coronary stenting [J].

Teirstein, PS ;

Massullo, V ;

Jani, S ;

Popma, JJ ;

Mintz, GS ;

Russo, RJ ;

Schatz, RA ;

Guarneri, EM ;

Steuterman, S ;

Morris, NB ;

Leon, MB ;

Tripuraneni, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (24) :1697-1703

[70] ANGIOTENSIN-CONVERTING ENZYME AND APOLIPOPROTEIN-E GENOTYPES AND RESTENOSIS AFTER CORONARY ANGIOPLASTY [J].

VANBOCKXMEER, FM ;

MAMOTTE, CDS ;

GIBBONS, FA ;

BURKE, V ;

TAYLOR, RR .

CIRCULATION, 1995, 92 (08) :2066-2071

← 1 2 3 4 5 6 7 8 →